Mathews Journal of Case Reports

2474-3666

Current Issue Volume 8, Issue 1 - 2023

Methylphenidate-Induced Kleptomania in a Child with Down Syndrome

Meltem Küçükdağ1,*, H Nejat Küçükdağ2

1Child and Adolescent Psychiatrist, Department of Child and Adolescent Psychiatry, Düzce Atatürk Devlet Hastanesi, Düzce, Turkey

2Assistant professor, Düzce University Faculty of Medicine, Düzce, Turkey

*Corresponding author: Dr. Meltem Küçükdağ, Child and Adolescent Psychiatrist, Department of Child and Adolescent Psychiatry, Düzce Atatürk Devlet Hastanesi, Düzce, Turkey. Tel: 05557213875 E-mail: [email protected]

Received Date: December 13, 2022

Publication Date: January 05, 2023

Citation: Küçükdağ M, et al. (2023). Methylphenidate-induced Kleptomania in a Child with Down Syndrome. Mathews J Case Rep. 8(1):82.

Copyright: Küçükdağ M, et al. © (2023)

ABSTRACT

Methylphenidate is the most preferred drug in the treatment of ADHD, which is one of the psychiatric diseases that often accompany Down's syndrome. Methylphenidate, which is used safely in children and adolescents, may rarely show unexpected side effects. In our study, we present a case of kleptomania induced by methylphenidate in a child with Down syndrome, which resolved with the discontinuation of the drug.

Keywords: Methylphenidate, Down’s Syndrome, Kleptomania


Creative Commons License

© 2015 Mathews Open Access Journals. All Rights Reserved.

Open Access by Mathews Open Access Journals is licensed under a
Creative Commons Attribution 4.0 International License.
Based On a Work at Mathewsopenaccess.com